MediciNova Inc (MNOV)
1.34
-0.02
(-1.47%)
USD |
NASDAQ |
Apr 24, 14:41
MediciNova Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0079M |
| March 31, 2022 | |
| December 31, 2021 | 0.0387M |
| September 30, 2021 | 0.2496M |
| June 30, 2021 | 0.3897M |
| March 31, 2021 | 20.10M |
| December 31, 2020 | 0.3587M |
| September 30, 2020 | 5.127M |
| June 30, 2020 | 1.201M |
| March 31, 2020 | 0.4189M |
| December 31, 2019 | 3.331M |
| September 30, 2019 | 3.175M |
| June 30, 2019 | 0.1804M |
| March 31, 2019 | 3.929M |
| December 31, 2018 | 1.515M |
| September 30, 2018 | 0.0152M |
| June 30, 2018 | 2.244M |
| March 31, 2018 | 39.03M |
| December 31, 2017 | 4.503M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.564M |
| June 30, 2017 | 2.664M |
| March 31, 2017 | 0.0662M |
| December 31, 2016 | 0.2352M |
| September 30, 2016 | 0.0138M |
| June 30, 2016 | 0.4403M |
| March 31, 2016 | 7.976M |
| December 31, 2015 | -0.0179M |
| September 30, 2015 | 16.20M |
| June 30, 2015 | 0.7411M |
| March 31, 2015 | 0.6381M |
| December 31, 2014 | 0.7695M |
| September 30, 2014 | 0.0333M |
| June 30, 2014 | 0.0406M |
| March 31, 2014 | 3.319M |
| December 31, 2013 | 0.071M |
| September 30, 2013 | 0.5343M |
| June 30, 2013 | 11.13M |
| March 31, 2013 | 1.636M |
| December 31, 2012 | 0.4528M |
| September 30, 2012 | 0.9268M |
| June 30, 2012 | 0.1377M |
| March 31, 2012 | 0.0279M |
| December 31, 2011 | 7.308M |
| September 30, 2011 | -0.2063M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
20.10M
Maximum
Mar 2021
2.034M
Average
0.2496M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4991M |
| Free Cash Flow | -7.452M |
| Free Cash Flow Per Share (Quarterly) | -0.0102 |
| Free Cash Flow Yield | -11.34% |